https://www.nature.com/articles/d41573-024-00188-z#:~:text=The%20FDA%20has%20approved%20BridgeBio's,tafamidis%20(Vyndaqel%2FVyndamax).
https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%E2%89%A590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-says-its-experimental-drug-cagrisema-has-similar-side-effects-2024-11-06/
https://www.amgen.com/newsroom/press-releases/2024/11/amgen-announces-robust-weight-loss-with-maritide-in-people-living-with-obesity-or-overweight-at-52-weeks-in-a-phase-2-study
https://www.rbcinsight.com/wm/Share/ResearchViewer/?SSS_82CF34D9C2A259E85270D35E5DCA41DD
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-says-its-experimental-drug-cagrisema-has-similar-side-effects-2024-11-06/#:~:text=The%20Danish%20drugmaker%20is%20due,a%20pancreas%20hormone%20called%20amylin.
https://investor.lilly.com/news-releases/news-release-details/lillys-phase-2-retatrutide-results-published-new-england-journal
https://qz.com/novo-nordisk-cagrisema-ozempic-1851691005
https://www.clinicaltrialsarena.com/analyst-comment/novo-nordisk-cagrisema-versus-zepbound/?cf-view
https://opco2.bluematrix.com/docs/pdf/4ca39dcf-d594-4ec6-85c0-73ad18ce1bd6.pdf
https://trials.lilly.com/en-US/trial/405675
edited photo from https://www.flickr.com/photos/bike/106066961
